Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_assertion type Assertion NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_head.
- NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_assertion description "[Taken together, these data provide proof of principle that the progesterone receptor of myelin-forming Schwann cells is a promising pharmacological target for therapy of CMT-1A.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_provenance.
- NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_assertion evidence source_evidence_literature NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_provenance.
- NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_assertion SIO_000772 14608378 NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_provenance.
- NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_assertion wasDerivedFrom befree-20140225 NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_provenance.
- NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_assertion wasGeneratedBy ECO_0000203 NP414547.RADgEzT1M2iVUPmTFkSyv1eHO4u2O62xUKaXBppBZ51GM130_provenance.